-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
REGENEREX PHARMA, INC. quarterly and annual Selling and Marketing Expense history and change rate from Q2 2019 to Q2 2023.
- REGENEREX PHARMA, INC. Selling and Marketing Expense for the quarter ending 30 Jun 2023 was $3,000.
- REGENEREX PHARMA, INC. annual Selling and Marketing Expense for 2020 was $8,771, a 48% decline from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)